Subsequent analysis of cytokines and additional indicators within the immune microenvironment revealed that MRD+ NB patients showed significantly elevated levels of IL-2 and IL-6 in bone marrow supernatant and NSE in peripheral blood when compared to MRD− patients. Here, IL2 is linked to neuroblastoma.